EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatitis B Doubly Spliced Protein (HBDSP) Promotes Epithelial‐Mesenchymal Transition, Migration, and Invasion via SP1/ETS1‐Dependent YAP Activation in Hepatoma Cells

Xiazhen Xu iD, Yibin Peng, Yuxin Ping, Tiantian Shao, Qiong Wu, Lu Zhang, Xu Lin, Changxi Yu, Wannan Chen iD

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.71046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Xiazhen Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical Univer…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Hepatitis B virus, Cell Movement, Carcinoma, Hepatocellular. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, National Natural Science Foundation of China, Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hepatitis B virus (HBV) infection remains a significant global health burden. Although the canonical HBV proteins are well‐studied, the pathological roles of HBV spliced variants and their encoded proteins are poorly understood. In this study, we investigate the cancer‐promoting potential of hepatitis B doubly spliced protein (HBDSP), encoded by the 2.2 kb doubly spliced variant of HBV, and its underlying mechanism in hepatocellular carcinoma (HCC). In vitro functional assays demonstrated that HBDSP induces epithelial‐mesenchymal transition (EMT) and enhances migration and invasion in HepG2 and Huh7 cells. Mechanistically, cellular and molecular approaches revealed that HBDSP enhanced the nuclear translocation of SP1 and ETS1, thereby facilitating their binding to the yes‐associated protein ( YAP ) promoter and activating YAP transcription. Inhibition of YAP using either the pharmacological inhibitor Verteporfin or YAP ‐specific siRNA effectively abolished HBDSP‐induced malignant phenotypes, confirming the essential role of YAP in this process. Notably, these effects were consistently validated in both HBV‐replicating HepG2.2.15 cells and HBV‐infected HepG2‐NTCP cells, further reinforcing the pathological relevance of HBDSP in HBV‐driven hepatocarcinogenesis. Taken together, we identify HBDSP as a novel viral effector that facilitates EMT, migration, and invasion in hepatoma cells via transcriptional activation of YAP in an SP1‐ and ETS1‐dependent manner. These findings suggest that HBDSP‐mediated activation of YAP may play a role in HBV‐driven HCC progression and could be explored further as a potential therapeutic axis, particularly in contexts where spliced HBV variants are prevalent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionHepatitis B virusCell MovementCarcinoma, HepatocellularTranscription FactorsAdaptor Proteins, Signal TransducingSp1 Transcription FactorLiver NeoplasmsProto-Oncogene Protein c-ets-1Viral ProteinsHost-Pathogen InteractionsHumansYAP-Signaling ProteinsCell Line, TumorHep G2 CellsNeoplasm Invasiveness

Stichwörter der Autor:innen

EMTHBDSPRNA splicingYAPhepatitis B virusinvasion

Substanzen

Transcription FactorsAdaptor Proteins, Signal TransducingSp1 Transcription FactorProto-Oncogene Protein c-ets-1YAP1 protein, humanYAP-Signaling ProteinsETS1 protein, humanSP1 protein, humanViral Proteins

Autor:innen und Institutionen

  • Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.

ORCID-Profile: Xiazhen Xu, Wannan Chen

Förderung

  • Natural Science Foundation of Fujian Province
  • National Natural Science Foundation of China
  • Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare
  • Fujian Provincial Finance Department
  • the Post-doctoral Foundation of Fujian Medical University

Zitieren

APA

Xu, X., Peng, Y., Ping, Y., Shao, T., Wu, Q., Zhang, L., Lin, X., Yu, C., & Chen, W. (2026). Hepatitis B Doubly Spliced Protein (HBDSP) Promotes Epithelial‐Mesenchymal Transition, Migration, and Invasion via SP1/ETS1‐Dependent YAP Activation in Hepatoma Cells. Journal of Medical Virology. https://doi.org/10.1002/jmv.71046

Vancouver

Xu X, Peng Y, Ping Y, Shao T, Wu Q, Zhang L, et al. Hepatitis B Doubly Spliced Protein (HBDSP) Promotes Epithelial‐Mesenchymal Transition, Migration, and Invasion via SP1/ETS1‐Dependent YAP Activation in Hepatoma Cells. Journal of Medical Virology. 2026. doi:10.1002/jmv.71046

BibTeX
@article{Xu2026,
  author = {Xu, Xiazhen and Peng, Yibin and Ping, Yuxin and Shao, Tiantian and Wu, Qiong and Zhang, Lu and Lin, Xu and Yu, Changxi and Chen, Wannan},
  title = {Hepatitis B Doubly Spliced Protein (HBDSP) Promotes Epithelial‐Mesenchymal Transition, Migration, and Invasion via SP1/ETS1‐Dependent YAP Activation in Hepatoma Cells},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.71046}
}
Kostenlos starten →